Home / Clinical Decision Support & Reference / Ellescope MpRisk

Ellescope MpRisk

by Ellescope · Based in United Kingdom → — A new landscape for digital maternity

Maternal-Fetal Medicine Obstetrics & Gynecology

Website

Claim this tool

Is this the maker? Claim the company →

Leave this field empty

Correct company / maker

Company website (optional)

Anything else? (optional)

Contact for pricing

Overview

Ellescope deploys a maternity risk-intelligence AI platform called MpRisk for comprehensive whole care record synthesis, inquiry, and shared care. The platform aims to close the maternity intelligence gap by equipping maternity services with tools to identify the care needs of expectant mothers across all races and ethnicities. It focuses on integrated care delivery, ending the crisis of poor data evaluation by combining AI with scientific expertise, and enhancing risk-based care coordination through maternal health screening and care pathway automation. MpRisk is an antenatal risk assessment and prediction system that identifies individual patients at risk of critically adverse maternal outcomes, providing a complete surveillance view of their medical and psychosocial risks and their association to pregnancy. The solution also incorporates clinically proven psychosocial analytical models to address health inequalities and offers operational uplift by handling data aggregation and processing from early screening to point-of-care antenatal assessments. Ellescope is committed to preventive care, upholding every person’s right to proactive intervention to prevent or minimize ill health for both mother and baby.

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Key Features

Antenatal risk assessment and prediction (MpRisk)
Identification of patients at risk of adverse maternal outcomes
Synthesis of whole care records
Complete surveillance view of medical and psychosocial risks
Clinically proven psychosocial analytical models
Data aggregation and processing from early screening to point-of-care assessments
Automated risk-based care referrals
Personalized care pathways
Early detection of poor maternal health
Preventive care

Use Cases

Identifying high-risk pregnancies
Personalizing antenatal and postnatal care plans
Reducing maternal deaths and morbidity
Addressing health inequalities in maternity care
Streamlining data evaluation for healthcare professionals
Enhancing care management planning

What Physicians Need to Know

Evidence Base

MpRisk is underpinned by biopsychosocial risk prediction AI models that dynamically evaluate maternal health risks. These models aggregate and synthesize clinical, psychosocial, and historical health data for expectant mothers to assess modifiable and non-modifiable risk factors impacting maternal outcomes. The solution incorporates 'clinically proven psychosocial analytical models' based on research highlighting social determinants of health as key contributors to poor maternal outcomes. Ellescope has also built an initial evidence base through collaboration with healthcare providers.

Clinical Validation Studies

A Phase-1 funded feasibility study demonstrated that MpRisk's proactive maternal health identification and stratification could effectively provide additional support to women across all maternity stages. This study, focusing on non-medical factors increasing risk during antenatal and postnatal stages, showed an overall improvement in 62.5% of patients' self-reported outcomes after attending group clinics informed by MpRisk. Ellescope plans to use Innovate UK grants to conduct a clinical study in secondary care and develop prospective clinical investigation protocols.

Differential Diagnosis Support

MpRisk is described as an 'antenatal risk assessment and prediction system that identifies individual patients at risk of the most critically adverse maternal outcomes.' It provides a 'complete surveillance view of the patient's medical and psychosocial risks and their association to pregnancy.' This suggests it supports identifying specific risks rather than a broad differential diagnosis across various conditions. Rule-based expert systems can be tailored for diagnosing prevalent maternal complications like preeclampsia, gestational diabetes mellitus, and maternal sepsis.

Clinical Workflow Integration

MpRisk is designed to do 'all the data aggregation and processing heavy-lifting, from early screening to point-of-care antenatal assessments.' Ellescope's broader digital maternity platform generates automated risk-based care referrals and personalized care pathways. The system aims to enhance and accelerate care management planning through maternal health screening and care pathway automation. Effective integration into clinical workflows is crucial for the adoption of AI-powered clinical decision support systems.

Decision Audit Trail

No specific information about a 'Decision Audit Trail' for Ellescope MpRisk is available in the provided search results. However, such features are generally important for transparency and accountability in clinical decision support systems.

Physician Tip

MpRisk can be a valuable tool for proactive maternal health management by providing an individualized risk assessment based on comprehensive clinical, psychosocial, and historical data. Leverage the automated risk-based care referrals and personalized care pathways to streamline patient management and intervention. The system's focus on identifying patients at risk of critical adverse maternal outcomes can aid in early detection and preventive care.

MpRisk performs data aggregation and processing from early screening to point-of-care antenatal assessments. Its wider digital maternity platform generates automated risk-based care referrals and personalized care pathways. Seamless integration with existing EHR systems and other healthcare IT infrastructure would be crucial to fully realize its benefits in automating workflows and syncing patient data.

At a glance

Pricing Contact for pricing

Deployment Cloud Based

Visit site

Details

Category	Clinical Decision Support & Reference, OB/GYN AI, Population Health Analytics
Pricing	Contact for pricing
Deployment	Cloud-based
Compliance
BAA Available	Unknown AI-estimated
HIPAA Compliant	Unknown AI-estimated
FDA Status	Unknown AI-estimated Ellescope is conducting clinical studies and building a comprehensive regulatory strategy, which may include pursuing FDA or similar regulatory body clearance in the future.
Integrations
EHR	Not specified
Specialties	Maternal-Fetal Medicine, Obstetrics & Gynecology

What the Web Says

Ellescope MpRisk is an AI-powered antenatal risk assessment and prediction system designed to identify individual patients at risk of adverse maternal outcomes. It aims to address health inequalities in maternity care by providing a comprehensive view of a patient's medical and psychosocial risks. Early research and feasibility studies have shown promising results, with reported improvements in patient-reported outcomes.

Overall: Positive

Strengths

Early detection of poor maternal health outcomes.
Identifies individual patients at risk of critically adverse maternal outcomes.
Provides a complete surveillance view of medical and psychosocial risks.
Combines AI with scientific expertise for rapid and analytical investigations.
Enhances and accelerates care management planning through maternal health screening and care pathway automation.
Clinically proven psychosocial analytical models embedded in the solution to address health inequalities.

Limitations

Limited publicly available reviews from physicians, healthcare IT, tech reviewers, Reddit, G2, or Capterra.
Newer company (founded in 2023), so long-term impact and widespread adoption are yet to be seen.

Based on reviews from: Ellescope Official Website, DigitalHealth.London, G2, Capterra

Last updated: 2026-09-19

Ratings & Reviews

No reviews yet. Be the first to review this tool!

Rate Ellescope MpRisk

Clinical Value

Ease of Use

Integration

Support & Docs

Value for Money

Your Name *

Email *

Your Role

Specialty

Your Review * (min 50 characters)

Press & Coverage

DigitalHealth.London

Reconfiguring Maternity through Comprehensive Maternal Health Screening - DigitalHealth.London

This case study highlights Ellescope's maternal health screening software, which uses a data-driven platform to assess health risks during pregnancy and empower healthcare professionals to intervene early and personalize patient care. Early research showed improved patient-reported outcomes for up to 62.5% of pregnant women.

2024-10

Ellescope

Ellescope awarded Innovate UK Biomedical Catalyst Funding

Ellescope received Innovate UK Biomedical Catalyst feasibility study funding to advance the development of its solution, including conducting a clinical study in secondary care and building a comprehensive regulatory and health economic strategy.

2024-unknown

Ellescope

Feasibility & proof of principle!

Ellescope's SBRI Phase-1 funded feasibility study demonstrated that proactive maternal health identification and stratification using their analytical tool, MpRisk, could effectively provide additional support to women across all maternity stages. The findings showed an overall improvement in 62.5% of patient's self-reported outcomes.

2023-07

Praxis Portfolio Ventures

Ellescope - Praxis Portfolio Ventures

Ellescope has developed MpRisk, a novel clinical tool underpinned by biopsychosocial risk prediction AI models that dynamically evaluate maternal health risks and predict common causes of maternal deaths, enabling preventive care actions. The platform also generates automated risk-based care referrals and personalized care pathways.

2026-unknown

Ellescope

Ellescope - A new landscape for digital maternity

Ellescope deploys a maternity risk-intelligence AI platform, MpRisk, for whole care record synthesis, inquiry, and shared care, aiming to close the maternity intelligence gap by identifying care needs across all races and ethnicities. The platform provides early detection of poor maternal health by assessing medical and psychosocial risks.

2023-unknown

Videos

Product demos, reviews, and walkthroughs for Ellescope MpRisk.

Loading videos...

View all on YouTube

Frequently Asked Questions

What is Ellescope MpRisk and how does it integrate into my existing clinical workflow for decision support?

Ellescope MpRisk is a clinical decision support tool designed to assess patient risk. It integrates into your workflow by providing risk scores and insights at the point of care, often through an interface with your Electronic Health Record (EHR) system, to aid in treatment planning and patient management.

How does Ellescope MpRisk ensure compliance with medical guidelines and regulatory requirements?

Ellescope MpRisk is developed to align with established medical guidelines and best practices. The system undergoes regular updates and validation processes to ensure it remains compliant with relevant healthcare regulations and provides evidence-based recommendations.

Are there any known limitations or patient populations for whom Ellescope MpRisk may not be suitable or accurate?

While Ellescope MpRisk is broadly applicable, there may be specific patient populations (e.g., very rare conditions, extreme age groups) where its predictive accuracy might be limited due to insufficient data in its training models. It's crucial to review the system's validation studies and consider individual patient factors.

What are the primary alternatives to Ellescope MpRisk for clinical risk assessment, and how does it compare in terms of features and accuracy?

Alternatives to Ellescope MpRisk can include other commercial risk stratification tools, proprietary algorithms developed by healthcare systems, or traditional clinical judgment combined with manual risk scores. Ellescope MpRisk differentiates itself through its specific algorithms and integration capabilities, which should be compared against alternatives based on published accuracy data and feature sets relevant to your practice.

What is the pricing structure for Ellescope MpRisk, and are there different tiers or subscription models available for individual practitioners versus larger institutions?

The pricing structure for Ellescope MpRisk typically varies based on the scale of implementation, ranging from per-user licenses for individual practitioners to institutional subscriptions for larger healthcare systems. Specific pricing models, including potential tiered options or volume discounts, would need to be discussed directly with the vendor.

How frequently is the risk assessment model updated in Ellescope MpRisk, and what is the process for incorporating new research or clinical evidence?

Ellescope MpRisk's risk assessment model is updated periodically to incorporate the latest medical research and clinical evidence. The vendor typically outlines a clear process for these updates, which may involve regular software releases and validation against new datasets to maintain its efficacy and relevance.

What kind of training and support are provided to physicians and their staff for effective utilization of Ellescope MpRisk?

Comprehensive training and support are usually provided to ensure effective utilization of Ellescope MpRisk. This often includes initial onboarding sessions, user manuals, online resources, and ongoing technical support to address any questions or issues that may arise during its use.